Press Releases

Catalyst Supporting Facebook Live Panel on Living with a Rare Disease Hosted by The Mighty Catalyst Kicks off Rare Reason Campaign CORAL GABLES, Fla. , Feb. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on

Company to Expand R&D Focus for Pipeline Growth to include Earlier Stage Programs and Validated Technology Platforms Firdapse® 2020 Net Revenues Estimate of approximately $118 Million ; about 16% Increase From 2019 Ended 2020 with Estimated $140 Million in Cash and Investments Company Highlights